CNBX Pharmaceuticals Inc. (CNBX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
-0.00005 (-33.33%)
At close: Oct 20, 2026
CNBX Pharmaceuticals Employees
CNBX Pharmaceuticals had 1 employees as of May 31, 2026. The number of employees did not change compared to the same quarter last year. That makes CNBX Pharmaceuticals the 44,029th largest employer in the world and 7,323rd in the United States.
Employees
1
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$462,091
Market Cap
192.58K
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| May 31, 2026 | 1 | 0 | - |
| Feb 28, 2026 | 1 | 0 | - |
| Aug 31, 2025 | 1 | -1 | -50.00% |
| Feb 28, 2025 | 1 | -1 | -50.00% |
| Aug 31, 2024 | 2 | 0 | - |
| Feb 29, 2024 | 2 | -1 | -33.33% |
| Aug 31, 2023 | 2 | -3 | -60.00% |
| Feb 28, 2023 | 3 | - | - |
| Nov 30, 2022 | 5 | -5 | -50.00% |
| Aug 31, 2022 | 5 | -5 | -50.00% |
| Aug 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Aug 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| May 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Feb 28, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Lyra Therapeutics | 27 |
| CERo Therapeutics Holdings | 8 |
| ZyVersa Therapeutics | 6 |
| Ampio Pharmaceuticals | 6 |
| Actavia Life Sciences | 1 |
CNBX Pharmaceuticals News
- 3 years ago - CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma - PRNewsWire
- 4 years ago - CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy - PRNewsWire
- 4 years ago - CNBX Patent Application "Composition and Method for Treating Cancer with Cannabinoids" Enters National Phase in US and Israel - PRNewsWire
- 4 years ago - CNBX Peer-reviewed Study: "Possible Future Therapeutic Value" for CNBX Proprietary Drug Candidate - PRNewsWire
- 4 years ago - CNBX Pharmaceuticals Announces New Patent Granted in Australia - PRNewsWire
- 4 years ago - CNBX Pharmaceuticals Granted Patent in Hong Kong - PRNewsWire
- 4 years ago - Cannabics Pharmaceuticals Changes Name to CNBX Pharmaceuticals - PRNewsWire
- 4 years ago - CNBX Selects API Supplier Purisys to Support Planned IND Fillings and Phase I/II (a) Clinical Trials - PRNewsWire